M
Mariana Mitewa
Researcher at Sofia University
Publications - 138
Citations - 1469
Mariana Mitewa is an academic researcher from Sofia University. The author has contributed to research in topics: Ligand & Crystal structure. The author has an hindex of 18, co-authored 138 publications receiving 1395 citations. Previous affiliations of Mariana Mitewa include Bulgarian Academy of Sciences & University of Zagreb.
Papers
More filters
Journal ArticleDOI
New Pr and Nd complexes containing TCNQ radicals
Loreto Ballester,Cristina Vico Alonso,M. Fonari,Angel Gutiérrez,Mariana Mitewa,M.F. Perpiñán,Kinga Suwinska +6 more
TL;DR: In this article, new compounds formed by reaction of TCNQ lanthanide complexes containing N-donor ligands have been obtained by controlling the reaction conditions, and different compounds of formulae Ln(N-N)x(TCNQ)3 (Ln=Pr, Nd; N-N=1,10-phenanthroline, dipyridylamine; x=2, 4) and Ln (N−N)4(TCNsQ)4 are isolated.
Journal ArticleDOI
Cobalt(II), Nickel(II) and Zinc(II) Complexes of Diethyl (2-Oxo-1-phenyl)ethylphosphonate-Synthesis and Structure
TL;DR: In this paper, the cobalt, nickel, and zinc complexes of diethyl (2-oxo-1-phenyl)ethylphosphonate were synthesized using the corresponding metal halides.
Journal ArticleDOI
Copper(II) Complexes with 1H-Indene-1,3(2H)-diones derivatives
Journal ArticleDOI
Structure of six- and seven-membered cyclic- β-diketones and their metal(II) complexes
Margarita Kashchieva,Neyko Stoyanov,Venelin Enchev,S. Minchev,Panayot R. Bontchev,Mariana Mitewa +5 more
TL;DR: In this paper, two new copper(II) complexes with physiologically active ligands containing both pyridine ring and cyclic β-diketones with different ring members were obtained with the metal to ligand ratio 1:2.
Journal ArticleDOI
Cytotoxicity of Monensic Acid and its Biometal(II) Complexes Against Anaerobic Bacterial Strain Clostridium Perfringens Spp.
TL;DR: Biometal(II) complexes improved the properties of Monensic acid in in vitro experiments, suggesting their possible practical application as more effective antibacterial agents than the non-coordinated antibiotic.